FDA Inspection 1019260 — Catalent Greenville Inc
The FDA completed an inspection of Catalent Greenville Inc on April 13, 2017 in Greenville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 13, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Greenville, NC (United States)